• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Atopic Dermatitis, Pediatric Rashes, and Contact Allergies: What’s New for PCPs from AAD 2025

Commentary
Video

Highlights from AAD 2025: Experts share updates on systemic therapy for atopic dermatitis, pediatric rashes, and contact dermatitis for PCPs.

Skin disorders remain some of the most frequent—and frustrating—conditions seen in primary care. In this 5-minute highlight reel from the 2025 American Academy of Dermatology meeting in Orlando, experts Katrina Abuabara, MD, Elizabeth Swanson, MD, and JiaDe Yu, MD, share the latest evidence and practical guidance on systemic therapy for atopic dermatitis in special populations, viral and fungal infections in children, and distinguishing allergic contact dermatitis from eczema. Their take-home messages help clinicians identify when to refer, what to monitor, and how to improve outcomes across all age groups.

Related Content
Genitourinary Syndrome of Menopause (GSM): Clinical FAQ for Primary Care / image credit ©christianchan/stock.adobe.com

Genitourinary Syndrome of Menopause (GSM): Clinical FAQ for Primary Care

Grace Halsey
October 31st 2025
Article

Genitourinary symptoms of menopause often are ignored--by patients and practitioners alike. Primary care clinicians are in a key position to identify, educate, and initiate treatment.

2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

Linda Stein Gold, MD;Sydney Jennings
August 25th 2025
Podcast

Linda Stein Gold, MD, reviews AAD’s 2025 updates on new topical and biologic options for adult atopic dermatitis.

Mayo Clinic Researcher on How Hormone Therapy May Influence Weight Loss Outcomes With Tirzepatide

Mayo Clinic Researcher on How Hormone Therapy May Influence Weight Loss Outcomes With Tirzepatide

Regina Castaneda, MD;Sydney Jennings
October 30th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 7th 2025
Podcast

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk

Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk

Grace Halsey
October 27th 2025
Article

The phase 3 E4COMFORT II trial found no impact on BP after 1 year of treatment in postmenopausal women with elevated HbA1c, lipids, and TGs.

FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause

FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause

Sydney Jennings
October 24th 2025
Article

The novel once-daily nonhormonal therapy offers a new option to offer women who prefer not to take HRT or for whom it is contraindicated.

© 2025 MJH Life Sciences

All rights reserved.